Bradley Gross, MD, joined the Department of Neurological Surgery as an assistant professor in July of 2016 specializing in cerebrovascular disease. His particular clinical and research interests include the comprehensive management of aneurysms, arteriovenous malformations, arteriovenous fistulas and cavernous malformations of the brain and spinal cord. He also performs embolization of brain and spinal cord tumors, revascularization for acute ischemic stroke as well as cervical, intracranial and venous stenting.
Dr. Gross graduated Summa Cum Laude from Northwestern University and then earned his medical degree from Northwestern University Medical School. He completed his internship and neurosurgical residency at Brigham and Women’s Hospital/Boston Children’s Hospital/Harvard Medical School. He then had the privilege to serve as an endovascular fellow at the Barrow Neurological Institute.
Dr. Gross' publications can be reviewed through the National Library of Medicine's publication database.
Specialized Areas of Interest
Board Certifications
American Board of Neurological Surgery
Hospital Privileges
Professional Organization Membership
Professional Activities
Education & Training
- BA with Honors, Chemistry, Northwestern University, 2004
- MD, Feinberg School of Medicine, Northwestern University, 2008
- Internship, Harvard Medical School, 2009
- Residency, Harvard Medical School, 2015
- Fellowship, Endovascular Neurosurgery, Barrow Neurological Institute, 2016
Research Activities
Embolization of the Middle Meningeal Artery With Onyx Liquid Embolic System for Subacute and Chronic Subdural Hematoma (EMBOLISE):
EMBOLISE is a multicenter randomized control trial evaluating the safety and efficacy of embolization of the middle meningeal artery with Onyx liquid embolisate in the management of chronic subdural hematoma. Dr. Gross is the UPMC principal investigator on this multicenter study.
US IDE Study of the Contour Neurovascular System for Intracranial Aneurysm Repair (NECC Trial):
The Contour Neurovascular System is a novel agent used in the intrasaccular treatment of intracranial aneurysms. UPMC is part of an initial multicenter effort employing this system. Dr. Gross is the UPMC principal investigator on this multicenter study.
A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the Route 92 Medical Reperfusion System (SUMMIT MAX):
The Route 92 system is a novel acute stroke embolectomy system that utilizes an ultra-large bore catheter to remove clots. This randomized controlled trial will compare this system to standard systems currently employed for stroke embolectomy. Dr. Gross is the UPMC principal investigator on this multicenter study.
Media Appearances
Greater obliteration and less in-stent stenosis after ATLAS stent coiling as compared to LVIS Jr
August 10, 2018
NeuroNews